See also Bova C, Pesavento R, Marchiori A, Palla A, Enea I, Pengo V, VisonaA, Noto A,
Prandoni P, for the TELESIO Study Group. Risk stratification and outcomes in …

Letter to the Editor The optimal management of acute pulmonary embolism remains a
compelling challenge. In recent years, with the improvement of prognostic stratification, it …

The present article addresses clinical challenges associated with the choice of the
anticoagulant agent, the definition of the duration of anticoagulant treatment and the …

Background: The prevalence of anticoagulant therapy-associated hemorrhagic
complications in hospitalized patients with pulmonary embolism (PE) has been scarcely …

Background. New management strategies, risk stratification procedures and treatments have
become available over the last years for patients with acute pulmonary embolism (PE) …

Importance The optimal duration of anticoagulation after a first episode of unprovoked
pulmonary embolism is uncertain. Objectives To determine the benefits and harms of an …

Direct oral anticoagulants are as effective as conventional anticoagulant treatment after
pulmonary embolism with a reduction in major bleeding when the single-drug approach was …

Objective To determine whether the pulmonary embolism (PE) categories of massive,
submassive, PE with no right ventricle dysfunction (NRVD), and subsegmental only (SSO) …

Background: Patients with a first episode of unprovoked pulmonary embolism have a high
risk of recurrent venous thromboembolism (VTE) after anticoagulation is discontinued …

Background: Post-pulmonary embolism (Post-PE) syndrome, comprising persistent
dyspnea, impaired exercise capacity and chronic thromboembolic pulmonary hypertension …